CSL Behring - Company & Market Research Reports

Home /
Companies /
CSL Behring

CSL Behring is a global leader in the plasma protein biotherapeutics industry. It specializes in bleeding disorder, fluid replacement, hereditary angioedema, immunoglobulin, pulmonary, and wound healing biotherapies. Its therapies are being used to treat coagulation disorders, primary immune deficiencies, neurological conditions, inherited respiratory diseases and a variety of others. The company was founded in 2000 and is based in King of Prussia, Pennsylvania.

REFINE BY

KEYWORD

Blood Plasma Derivatives Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, Application, and End User

 Report
March 2023
209 Pages
Global

From

€3962EUR$4,450USD£3,424GBP

Dermatomyositis - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1335EUR$1,500USD£1,154GBP

CRISPR Technologies: Intellectual Property Landscape(Featuring Historical and Contemporary Patent Filing Trends, Prior Art Search Expressions, Patent Valuation Analysis, Patentability, Freedom to Operate, Pockets of Innovation, Existing White Spaces, and Claims Analysis)

 Report
August 2022
121 Pages
Global

From

€1157EUR$1,299USD£999GBP

Atherosclerotic Cardiovascular Disease (ASCVD) - Market Insight, Epidemiology and Market Forecast - 2034

 Report
October 2024
249 Pages
Global

From

€7078EUR$7,950USD£6,117GBP

Immunoglobulins Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3998EUR$4,490USD£3,455GBP

NEED HELP FINDING THE RIGHT PRODUCT? Farid will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Intravenous Immunoglobulin Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3998EUR$4,490USD£3,455GBP

Subcutaneous Immunoglobulin - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
120 Pages
Global

From

€4229EUR$4,750USD£3,655GBP

Pharmerging Market by Product (OTC Drugs, Pharmaceuticals), Indication (Cancer & Autoimmune Diseases, Lifestyle Diseases), Distribution - Forecast 2024-2030

 Report
March 2024
191 Pages
Global

From

€3156EUR$3,545USD£2,728GBP

€3507EUR$3,939USD£3,031GBP

Myositis - Pipeline Insight, 2025

 Drug Pipelines
April 2025
80 Pages
Global

From

€1781EUR$2,000USD£1,539GBP

U.S. Intravenous Immunoglobulin Market Size, Share & Trends Analysis Report By Application (Primary Immunodeficiency Diseases, Multifocal Motor Neuropathy), By Distribution Channel, And Segment Forecasts, 2023 - 2030

 Report
May 2023
85 Pages
United States

From

€5297EUR$5,950USD£4,578GBP

Human Plasma-Derived Therapeutics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
May 2023
98 Pages
Global

From

€3500EUR$4,211USD£3,131GBP

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Market Insight, Epidemiology and Market Forecast - 2034

 Report
June 2024
200 Pages
Global

From

€7078EUR$7,950USD£6,117GBP

Antiviral Combination Therapy Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F

 Report
May 2024
184 Pages
Global

From

€4006EUR$4,500USD£3,462GBP

Hereditary Testing Market by Product Type (Instruments, Reagents & Kits, Services), Technology (Microarray, NGS, PCR), Testing Type, Application, End User - Global Forecast 2025-2030

 Report
August 2025
188 Pages
Global

From

€3156EUR$3,545USD£2,728GBP

€3507EUR$3,939USD£3,031GBP

Rare Hematology Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
November 2023
113 Pages
Global

From

€3500EUR$4,211USD£3,131GBP

Blood Plasma Colloid Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2023
103 Pages
Global

From

€3500EUR$4,211USD£3,131GBP

Disease Analysis: Hemophilia

 Report
June 2021
102 Pages
Global

€19587EUR$22,000USD£16,928GBP

Plasma Protein Therapeutics Market based on Type, Application and Geography - Global Forecast to 2027

 Report
July 2021
128 Pages
Global

From

€3561EUR$4,000USD£3,078GBP

Alpha 1 Antitrypsin Deficiency Treatment Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
November 2024
75 Pages
Global

From

€3500EUR$4,211USD£3,131GBP

Alpha-1 Antitrypsin Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
86 Pages
Global

From

€3500EUR$4,211USD£3,131GBP

275 Results (Page 11 of 14)
- 1
- 9
- 10
- 11
- 12
- 13

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.